サマリー

中東・アフリカの受託製造市場は、2023年から2030年の予測期間に5.3%の大幅なCAGRを記録すると予測されます。この新しい市場レポートは、歴史的な年2021年のデータを含み、計算の基準年は2022年で、予測期間は2023年から2030年です
市場セグメンテーション
中東・アフリカの受託製造市場：製品別（医療機器製造、医薬品製造）、エンドユーザー別（相手先ブランド製造会社、医療機器会社、製薬会社、バイオテクノロジー会社、バイオ医薬品会社、研究機関）、流通チャネル（直接入札、小売販売、その他）、国（南アフリカ、サウジアラビア、アメリカ、エジプト、イスラエル、その他中東・アフリカ） 産業動向と2030年までの予測
中東・アフリカの受託製造市場の成長に寄与する主な要因としては、以下のようなものが挙げられます：
- ヘルスケア分野での技術進歩の拡大
- 費用対効果の向上とキープレイヤーのグローバルなプレゼンス
市場のプレーヤー：

中東・アフリカの受託製造市場で事業を展開している主なプレイヤーは以下の通りです：

- アエノバグループ
- サーモフィッシャーサイエンティフィック社（Thermo Fisher Scientific, Inc.
- エボニック・インダストリーズ・アグ
- ロンザ
- ベーリンガーインゲルハイムバイオファーマシューティカルズGmbH.
- キャタレント社
- サンファーマシューティカルインダストリー株式会社
- ニプロファーマ株式会社
- ファイザー株式会社（Pfizer Inc.
- レシファームAB
- ヴェター
- TEコネクティビティ
- メルクKGaA
- アルマックグループ
- ジークフリードホールディングAG
- ジュビラント・ファーマ・リミテッド
- アビッドバイオサービシーズ株式会社
- バクスター
- キンブルエレクトロニクス株式会社
- ファマーヘルスケアサービス
- アッヴィー社（AbbVie Inc.

ページTOPに戻る

目次

TABLE OF CONTENTS
1 INTRODUCTION 42
1.1 OBJECTIVES OF THE STUDY 42
1.2 MARKET DEFINITION 42
1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET 42
1.4 CURRENCY AND PRICING 44
1.5 LIMITATIONS 44
1.6 MARKETS COVERED 44
2 MARKET SEGMENTATION 47
2.1 MARKETS COVERED 47
2.2 GEOGRAPHICAL SCOPE 48
2.3 YEARS CONSIDERED FOR THE STUDY 49
2.4 DBMR TRIPOD DATA VALIDATION MODEL 50
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 53
2.6 MULTIVARIATE MODELLING 54
2.7 PRODUCT SEGMENT LIFELINE CURVE 54
2.8 MARKET END USER COVERAGE GRID 55
2.9 DBMR MARKET POSITION GRID 56
2.10 VENDOR SHARE ANALYSIS 57
2.11 SECONDARY SOURCES 58
2.12 ASSUMPTIONS 58
3 EXECUTIVE SUMMARY 59
4 PREMIUM INSIGHTS 61
4.1 PESTEL ANALYSIS 64
4.2 PORTER'S FIVE FORCES 65
4.3 STRATEGIC INITIATIVES: 66
5 REGULATORY FRAMEWORK 67
5.1 REGULATORY SCENARIO BY FDA 67
5.2 REGULATORY SCENARIO IN AUSTRALIA 68
5.3 REGULATORY SCENARIO IN EUROPE FOR MEDICINES 69
6 MARKET OVERVIEW 70
6.1 DRIVERS 72
6.1.1 COST-EFFECTIVENESS FOR THE MANUFACTURING COMPANIES 72
6.1.2 RISE OF TECHNOLOGICAL ADVANCEMENTS IN CONTRACT MANUFACTURING 72
6.1.3 MIDDLE EAST & AFRICA PRESENCE AND CONNECTED NETWORK 73
6.2 RESTRAINTS 73
6.2.1 STRINGENT REGULATIONS AMONG VARIOUS JURISDICTIONS 73
6.2.2 RISK OF CONFIDENTIAL INFORMATION 74
6.3 OPPORTUNITIES 74
6.3.1 PATENT EXPIRY AND INCREASING DEMAND FOR GENERIC DRUGS 74
6.3.2 GROWING EXPENSES ON THE DEVELOPMENT OF HEALTHCARE INFRASTRUCTURE 75
6.3.3 INCREASE IN NUMBER OF STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 75
6.4 CHALLENGES 76
6.4.1 INTELLECTUAL PROPERTY RISKS 76
6.4.2 INCREASE IN NUMBER OF PHARMACEUTICAL COMPANIES TO SET UP THEIR MANUFACTURING SITES 76
7 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT 77
7.1 OVERVIEW 78
7.2 PHARMACEUTICAL PRODUCTS MANUFACTURING 81
7.2.1 TYPES OF PRODUCTS 82
7.2.1.1 TABLETS 82
7.2.1.2 CAPSULES 82
7.2.1.3 BIOLOGICS 83
7.2.1.4 SMALL MOLECULE 83
7.2.1.5 CELL & GENES MANUFACTURING 83
7.2.1.6 NUTRACEUTICALS 83
7.2.1.7 OTHERS 83
7.2.2 TYPE OF SERVICES 83
7.2.2.1 DRUG DEVELOPMENT SERVICES 84
7.2.2.2 TABLET MANUFACTURING SERVICES 84
7.2.2.3 BIOLOGICS API MANUFACTURING 84
7.2.2.4 BIOLOGICS FDF MANUFACTURING SERVICES 84
7.2.2.5 OTHERS 84
7.2.3 BY DOSAGE FORM 84
7.2.3.1 SOLID FORMULATIONS 85
7.2.3.2 LIQUID FORMULATIONS 85
7.2.3.2.1 INJECTABLE 85
7.2.3.2.2 SYRUPS 85
7.2.3.3 SEMI-SOLID FORMULATIONS 85
7.2.3.4 TOPICAL DRUG FORMULATIONS 85
7.2.3.5 OTHERS 85
7.3 MEDICAL DEVICE MANUFACTURING 86
7.3.1 TYPE OF DEVICES 87
7.3.1.1 SYRINGES AND NEEDLES 88
7.3.1.2 INFUSION DEVICES & ADMINISTRATION SETS 88
7.3.1.3 MEDICAL ACCESSORIES, COMPONENTS & CONSUMABLES 88
7.3.1.4 DISPOSABLES 88
7.3.1.5 IVD DEVICES 89
7.3.1.6 CARDIOVASCULAR DEVICES 89
7.3.1.7 DIABETES CARE DEVICES 89
7.3.1.8 GENERAL SURGERY DEVICES 89
7.3.1.9 ORTHOPEDIC DEVICES 89
7.3.1.10 RESPIRATORY DEVICES 89
7.3.1.11 OPHTHALMIC DEVICES 89
7.3.1.12 DENTAL DEVICES 89
7.3.1.13 GYNECOLOGY/UROLOGY DEVICES 89
7.3.1.14 LABORATORY EQUIPMENT 89
7.3.2 TYPE OF SERVICES 90
7.3.2.1 MEDICAL DEVICE DESIGN AND DEVELOPMENT 90
7.3.2.2 DEVICE ASSEMBLY 90
7.3.2.3 REGULATORY ASSISTANCE 90
7.3.2.4 PACKAGING & LABELLING 90
7.3.2.5 STERILIZATION SERVICES 91
7.3.2.6 TRAINING AND VALIDATION 91
7.3.2.7 QUALITY ASSURANCE 91
7.3.2.8 OTHERS 91
7.3.3 BY DEVICE CLASS 91
7.3.3.1 CLASS I MEDICAL DEVICES 92
7.3.3.2 CLASS IIA MEDICAL DEVICES 92
7.3.3.3 CLASS IIB MEDICAL DEVICES 92
7.3.3.4 CLASS III MEDICAL DEVICES 92
8 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY END USER 93
8.1 OVERVIEW 94
8.2 PHARMACEUTICAL COMPANIES 97
8.3 BIOTECHNOLOGY COMPANIES 97
8.4 BIOPHARMA COMPANIES 98
8.5 MEDICAL DEVICES COMPANIES 99
8.6 ORIGINAL EQUIPMENT MANUFACTURER 99
8.7 RESEARCH INSTITUTES 100
9 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL 101
9.1 OVERVIEW 102
9.2 RETAIL SALES 105
9.3 DIRECT TENDER 106
9.4 OTHERS 107
10 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY REGION 108
10.1 MIDDLE EAST AND AFRICA 109
10.1.1 SOUTH AFRICA 122
10.1.2 SAUDI ARABIA 130
10.1.3 U.A.E. 138
10.1.4 EGYPT 146
10.1.5 ISRAEL 154
10.1.6 REST OF MIDDLE EAST AND AFRICA 162
11 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET: COMPANY LANDSCAPE 163
11.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 163
12 SWOT ANALYSIS 164
13 COMPANY PROFILE 165
13.1 AENOVA GROUP 165
13.1.1 COMPANY SNAPSHOT 165
13.1.2 COMPANY SHARE ANALYSIS 165
13.1.3 PRODUCT PORTFOLIO 166
13.1.4 RECENT DEVELOPMENTS 166
13.2 THERMO FISHER SCIENTIFIC INC. 167
13.2.1 COMPANY SNAPSHOT 167
13.2.2 REVENUE ANALYSIS 168
13.2.3 COMPANY SHARE ANALYSIS 168
13.2.4 PRODUCT PORTFOLIO 169
13.2.5 RECENT DEVELOPMENTS 169
13.3 EVONIK INDUSTRIES AG 170
13.3.1 COMPANY SNAPSHOT 170
13.3.2 REVENUE ANALYSIS 170
13.3.3 COMPANY SHARE ANALYSIS 171
13.3.4 PRODUCT PORTFOLIO 171
13.3.5 RECENT DEVELOPMENTS 171
13.4 LONZA 172
13.4.1 COMPANY SNAPSHOT 172
13.4.2 REVENUE ANALYSIS 172
13.4.3 COMPANY SHARE ANALYSIS 173
13.4.4 PRODUCT PORTFOLIO 173
13.4.5 RECENT DEVELOPMENTS 174
13.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH. 175
13.5.1 COMPANY SNAPSHOT 175
13.5.2 REVENUE ANALYSIS 175
13.5.3 COMPANY SHARE ANALYSIS 176
13.5.4 PRODUCT PORTFOLIO 176
13.5.5 RECENT DEVELOPMENTS 176
13.6 ABBVIE INC. 177
13.6.1 COMPANY SNAPSHOT 177
13.6.2 REVENUE ANALYSIS 177
13.6.3 PRODUCT PORTFOLIO 178
13.6.4 RECENT DEVELOPMENT 178
13.7 ALMAC GROUP 179
13.7.1 COMPANY SNAPSHOT 179
13.7.2 PRODUCT PORTFOLIO 179
13.7.3 RECENT DEVELOPMENTS 179
13.8 AVID BIOSERVICES, INC. 180
13.8.1 COMPANY SNAPSHOT 180
13.8.2 REVENUE ANALYSIS 180
13.8.3 PRODUCT PORTFOLIO 181
13.8.4 RECENT DEVELOPMENT 181
13.9 BAXTER 182
13.9.1 COMPANY SNAPSHOT 182
13.9.2 REVENUE ANALYSIS 182
13.9.3 PRODUCT PORTFOLIO 183
13.9.4 RECENT DEVELOPMENTS 184
13.10 CATALENT, INC 185
13.10.1 COMPANY SNAPSHOT 185
13.10.2 REVENUE ANALYSIS 185
13.10.3 PRODUCT PORTFOLIO 186
13.10.4 RECENT DEVELOPMENT 186
13.11 FAMAR HEALTH CARE SERVICES 187
13.11.1 COMPANY SNAPSHOT 187
13.11.2 PRODUCT PORTFOLIO 187
13.11.3 RECENT DEVELOPMENTS 187
13.12 JUBILANT PHARMA LIMITED 188
13.12.1 COMPANY SNAPSHOT 188
13.12.2 REVENUE ANALYSIS 188
13.12.3 PRODUCT PORTFOLIO 189
13.12.4 RECENT DEVELOPMENT 189
13.13 KIMBALL INTERNATIONAL 190
13.13.1 COMPANY SNAPSHOT 190
13.13.2 REVENUE ANALYSIS 190
13.13.3 PRODUCT PORTFOLIO 191
13.13.4 RECENT DEVELOPMENT 191
13.14 MERCK KGAA 192
13.14.1 COMPANY SNAPSHOT 192
13.14.2 REVENUE ANALYSIS 192
13.14.3 PRODUCT PORTFOLIO 193
13.14.4 RECENT DEVELOPMENTS 193
13.15 NIPR0 194
13.15.1 COMPANY SNAPSHOT 194
13.15.2 REVENUE ANALYSIS 194
13.15.3 PRODUCT PORTFOLIO 195
13.15.4 RECENT DEVELOPMENT 195
13.16 PFIZER INC 196
13.16.1 COMPANY SNAPSHOT 196
13.16.2 REVENUE ANALYSIS 196
13.16.3 PRODUCT PORTFOLIO 197
13.16.4 RECENT DEVELOPMENT 197
13.17 RECIPHARM AB. 198
13.17.1 COMPANY SNAPSHOT 198
13.17.2 REVENUE ANALYSIS 198
13.17.3 PRODUCT PORTFOLIO 199
13.17.4 RECENT DEVELOPMENT 199
13.18 SIEGFRIED HOLDING AG 200
13.18.1 COMPANY SNAPSHOT 200
13.18.2 REVENUE ANALYSIS 200
13.18.3 PRODUCT PORTFOLIO 201
13.18.4 RECENT DEVELOPMENTS 201
13.19 SUN PHARMACEUTICAL INDUSTRIES LTD 202
13.19.1 COMPANY SNAPSHOT 202
13.19.2 REVENUE ANALYSIS 202
13.19.3 PRODUCT PORTFOLIO 203
13.19.4 RECENT DEVELOPMENT 203
13.20 TE CONNECTIVITY 204
13.20.1 COMPANY SNAPSHOT 204
13.20.2 REVENUE ANALYSIS 204
13.20.3 PRODUCT PORTFOLIO 205
13.20.4 RECENT DEVELOPMENT 205
13.21 VETTER PHARMA-FERTIGUNG GMBH & CO. KG 206
13.21.1 COMPANY SNAPSHOT 206
13.21.2 PRODUCT PORTFOLIO 206
13.21.3 RECENT DEVELOPMENTS 206
14 QUESTIONNAIRE 207
15 RELATED REPORTS 210

ページTOPに戻る

図表リスト

LIST OF TABLES
TABLE 1 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 57
TABLE 2 MIDDLE EAST & AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 58
TABLE 3 MIDDLE EAST & AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 59
TABLE 4 MIDDLE EAST & AFRICA TYPES OF PRODUCTS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 59
TABLE 5 MIDDLE EAST & AFRICA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 60
TABLE 6 MIDDLE EAST & AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 61
TABLE 7 MIDDLE EAST & AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 62
TABLE 8 MIDDLE EAST & AFRICA MEDICAL DEVICE MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 63
TABLE 9 MIDDLE EAST & AFRICA CONSUMABLES AND ACCESSORIES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 64
TABLE 10 MIDDLE EAST & AFRICA TYPE OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 65
TABLE 11 MIDDLE EAST & AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 67
TABLE 12 MIDDLE EAST & AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 68
TABLE 13 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 73
TABLE 14 MIDDLE EAST & AFRICA PHARMACEUTICAL COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 74
TABLE 15 MIDDLE EAST & AFRICA BIOTECHNOLOGY COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 75
TABLE 16 MIDDLE EAST & AFRICA BIOPHARMA COMPANIES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 75
TABLE 17 MIDDLE EAST & AFRICA AMBULATORY SURGICAL CENTERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 76
TABLE 18 MIDDLE EAST & AFRICA ORIGINAL EQUIPMENT MANUFACTURER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 19 MIDDLE EAST & AFRICA RESEARCH INSTITUTES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 77
TABLE 20 MIDDLE EAST & AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 81
TABLE 21 MIDDLE EAST & AFRICA RETAIL SALES IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 82
TABLE 22 MIDDLE EAST & AFRICA DIRECT TENDER IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 83
TABLE 23 MIDDLE EAST & AFRICA OTHERS IN CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2030 (USD MILLION) 84
TABLE 24 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 90
TABLE 25 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 90
TABLE 26 MIDDLE EAST AND AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 90
TABLE 27 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 91
TABLE 28 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, 2021-2030, 2021-2030 (UNIT) 91
TABLE 29 MIDDLE EAST AND AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP 92
TABLE 30 MIDDLE EAST AND AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 92
TABLE 31 MIDDLE EAST AND AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 92
TABLE 32 MIDDLE EAST AND AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93
TABLE 33 MIDDLE EAST AND AFRICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 93
TABLE 34 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 94
TABLE 35 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 95
TABLE 36 MIDDLE EAST AND AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 96
TABLE 37 MIDDLE EAST AND AFRICA TYPE OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 97
TABLE 38 MIDDLE EAST AND AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 97
TABLE 39 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 98
TABLE 40 MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 98
TABLE 41 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 42 SOUTH AFRICA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 43 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 99
TABLE 44 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 100
TABLE 45 SOUTH AFRICA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 100
TABLE 46 SOUTH AFRICA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 100
TABLE 47 SOUTH AFRICA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 48 SOUTH AFRICA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 49 SOUTH AFRICA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 101
TABLE 50 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 102
TABLE 51 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 103
TABLE 52 SOUTH AFRICA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 104
TABLE 53 SOUTH AFRICA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 105
TABLE 54 SOUTH AFRICA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 105
TABLE 55 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 106
TABLE 56 SOUTH AFRICA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 106
TABLE 57 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 58 SAUDI ARABIA PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 59 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 107
TABLE 60 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 108
TABLE 61 SAUDI ARABIA TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 108
TABLE 62 SAUDI ARABIA BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 108
TABLE 63 SAUDI ARABIA BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 64 SAUDI ARABIA LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 65 SAUDI ARABIA MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 109
TABLE 66 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 110
TABLE 67 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 111
TABLE 68 SAUDI ARABIA TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 112
TABLE 69 SAUDI ARABIA TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 113
TABLE 70 SAUDI ARABIA BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 113
TABLE 71 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 114
TABLE 72 SAUDI ARABIA CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 114
TABLE 73 UA.E. CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 74 UA.E. PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 75 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 115
TABLE 76 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 116
TABLE 77 UA.E. TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 116
TABLE 78 UA.E. BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 116
TABLE 79 UA.E. BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 80 UA.E. LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 81 UA.E. MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 117
TABLE 82 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 118
TABLE 83 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 119
TABLE 84 UA.E. TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 120
TABLE 85 UA.E. TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 121
TABLE 86 UA.E. BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 121
TABLE 87 UA.E. CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 122
TABLE 88 UA.E. CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 122
TABLE 89 EGYPT CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123
TABLE 90 EGYPT PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123
TABLE 91 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 123
TABLE 92 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 124
TABLE 93 EGYPT TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 124
TABLE 94 EGYPT BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 124
TABLE 95 EGYPT BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 125
TABLE 96 EGYPT LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 125
TABLE 97 EGYPT MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 125
TABLE 98 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 126
TABLE 99 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 127
TABLE 100 EGYPT TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 128
TABLE 101 EGYPT TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 129
TABLE 102 EGYPT BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 129
TABLE 103 EGYPT CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 130
TABLE 104 EGYPT CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 130
TABLE 105 ISRAEL CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 131
TABLE 106 ISRAEL PHARMACEUTICAL PRODUCTS MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 131
TABLE 107 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 131
TABLE 108 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 132
TABLE 109 ISRAEL TYPES OF PRODUCT IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 132
TABLE 110 ISRAEL BY SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 132
TABLE 111 ISRAEL BY DOSAGE FORM IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 133
TABLE 112 ISRAEL LIQUID FORMULATIONS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 133
TABLE 113 ISRAEL MEDICAL DEVICES MANUFACTURING IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 133
TABLE 114 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 134
TABLE 115 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (UNIT) 135
TABLE 116 ISRAEL TYPES OF DEVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (ASP) 136
TABLE 117 ISRAEL TYPES OF SERVICES IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 137
TABLE 118 ISRAEL BY DEVICE CLASS IN CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 137
TABLE 119 ISRAEL CONTRACT MANUFACTURING MARKET, BY END USER, 2021-2030 (USD MILLION) 138
TABLE 120 ISRAEL CONTRACT MANUFACTURING MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 138
TABLE 121 REST OF MIDDLE EAST AND AFRICA CONTRACT MANUFACTURING MARKET, BY PRODUCT, 2021-2030 (USD MILLION) 139